Not only do women get more migraines than men, but a new study shows they also experience them for a longer duration. Many scientists point to hormones as the cause of most migraines in women, but ...

Please provide your email address to receive an email when new articles are posted on . The effect of vestibular rehabilitation showed a “clinically important” pooled mean difference. Overall results ...

If you spend any time online, you already know that IYKYK is shorthand for a shared truth — a wink to people who’ve lived it and don’t need the backstory. But when it comes to migraines, knowing is ...

Current medical guidelines discourage the use of combined oral contraceptives (COCs) among people who experience migraine with aura—a type of migraine accompanied by temporary neurological ...

Approximately two-thirds of patients with migraines had vestibular symptoms, and one-sixth had symptoms that met criteria for vestibular migraines. Migraine disability, anxiety, depression, and sleep ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

Higher surprisal scores, reflecting unusual daily experiences, were tied to migraine attacks within a day. Surprisal's link to migraine risk was stronger at 24 hours than 12 hours. Findings support ...

Food, stress, sleep and weather may not be the only triggers to consider when preventing migraines—how stable your daily routine is could play an important role too. Harvard and Massachusetts General ...

Mr. Zeller is the author of “The Headache: The Science of a Most Confounding Affliction.” “What a headache!” we might say about the stalled subway or the broken printer. It’s shorthand for life’s ...

Lakshini Gunasekera receives funding from the Victorian Government Catalyst grant program to investigate hormonal therapies for menstrual migraine. Jayashri Kulkarni is a National Health and Medical ...

ROCKAWAY, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCore™ Sapphire (nVNS) has ...

The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas and TOKYO, Sept. 24, 2025 /PRNewswire/ --The Digital Migraine Treatment Devices Market is witnessing ...